News Focus
News Focus
Followers 67
Posts 2907
Boards Moderated 0
Alias Born 04/22/2022

Re: HyGro post# 559804

Monday, 01/16/2023 12:06:45 PM

Monday, January 16, 2023 12:06:45 PM

Post# of 821994
How could HyGro possibly have access to more information than the JAMA physicians?

Nothing is hidden or secret if HyGro knows about it. Explore all the supplements attached to the JAMA publication.

Your statements are 100% verifiably false. It is documented and published. PFS and the original trial protocol were covered extensively in the independent peer review. Furthermore, the implications of pseudo-progression are well-documented in the documents submitted to the JAMA peer-review, and pseudo is well-documented in the medical literature in general.

If you want to learn about the original trial protocol all those years ago, consult JAMA and the peer review documents that JAMA has published and made available worldwide. The links are included on the DCVax-L P3 peer review page at the JAMA Oncology website linked below.



https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847




https://ceoworld.biz/2022/04/05/top-5-medical-journals-in-the-world-everyone-should-know-about/

The statistical analysis plan was approved by the regulators. Ashkan is a careful and precise brain surgeon—listen to his words:

Dr. Ashkan said this in June 2022. Skip to timestamp 14:55 of the ASCO video.




Dr. Ashkan was the chief investigator of the murcidencel trial for patients in Europe. At King’s College in London, Ashkan is the lead clinician for neuro-oncology and the chair of the King’s Neurosciences Clinical Trial Unit. He is a world-renowned cancer trial expert. A few years ago, Professor Ashkan was named the UK Clinician of the Year by The Brain Tumour Charity. Additionally, Ashkan serves as an advisor to the U.K. government.

https://www.kcl.ac.uk/people/keyoumars-ashkan




https://cdn.jamanetwork.com/ama/content_public/journal/oncology/0/coi220066supp1_prod_1668698380.81699.pdf?Expires=1676780989&Signature=I5OpHDA5H3FIhuKxdijPEWnsIIQq5zwNcKvqL6P5Rjy8uumxSPgPb6sc1Uhl2Wd5mP9GTcsZoXzSlU8Pf2pclbrBsWmZiTnkWo0zhvIql90z~mj5MXSYPZ3gQ0~PQBiPDuTlDqz4xMimD33hw45NPJ6B6oRoWYMxsCI-i6Rb3ZSi3g6Iq5~c~Y8QK5CwrPjd3cnN8qcGvERrm0dDqKfRtDYbWj84UsmsdXKw260NwhXHLJjZPEn2EkM3L~ClimScT7ASS9Tcpkoz8Ttw7sf4fe6Iei-Y6hdgg1tY~Tx~zYMftcTOSNQrE3bcxfVcfL7ID0jE5zCGgf1DO9pbbhfrUQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA

Contact JAMA: jamaonc@jamanetwork.org


Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News